Company Overview
About OpenEvidence
OpenEvidence founded 2022 by Daniel Nadler, headquartered in Miami with SF AI research center. AI copilot for physicians analyzing peer-reviewed literature (NEJM, JAMA) for clinical decisions. Free for verified physicians, revenue from advertising and enterprise.
Business Model & Competitive Advantage
Raised ~$700M over 12 months: $75M Series A (Feb 2025, Sequoia), $210M Series B (Jul 2025, GV/Kleiner), $200M Series C (Oct 2025), $250M Series D (Jan 2026, Thrive/DST Global) at $12B. One of fastest to $100M ARR in history.
Competitive Landscape 2025–2026
430K+ verified US physicians (~40% of all US doctors). 18M clinical consultations monthly (Dec 2025).
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
OpenEvidence is an emerging player bringing innovative solutions to the Healthcare Tech market.
Growth Stage
OpenEvidence has achieved $100M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Compare OpenEvidence with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Start Comparison →Claim This Profile
Are you from OpenEvidence? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim OpenEvidence Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention OpenEvidence vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →